THE ROLE OF INHIBITORY METABOLITES IN THE P450-BASED DRUG-DRUG INTERACTIONS OF AMIODARONE

被引：0
|
作者：
McDonald, Matthew G. [1 ]
Rettie, Allan E. [1 ]
机构：
[1] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA
来源：
DRUG METABOLISM REVIEWS | 2015年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P198
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [21] Understanding cooperativity in human P450 mediated drug-drug interactions
    Sligar, Stephen G.
    Denisov, Ilia G.
    DRUG METABOLISM REVIEWS, 2007, 39 (2-3) : 567 - 579
  • [22] Drug-Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In Rats
    Wang, Qiong
    Wang, Haiyun
    Zhong, Youyan
    Zhang, Qiang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 4207 - 4213
  • [23] In Vitro Techniques to Study Drug-Drug Interactions of Drug Metabolism: Cytochrome P450
    Houston, J. Brian
    Galetin, Aleksandra
    ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, 2010, : 169 - 215
  • [24] Analysis of the contribution of circulating metabolites to inhibitory drug-drug interactions: Literature evaluation based on the metabolism and transport drug interaction database
    Fujioka, Yasushi
    Yeung, Catherine K.
    Hachad, Houda
    Levy, Rene H.
    Isoherranen, Nina
    DRUG METABOLISM REVIEWS, 2009, 41 : 72 - 72
  • [25] Mechanism-based inhibition of cytochrome P450 in vitro: Implications for drug-drug interactions
    Dilworth, C
    Abernethy, L
    Fenn, P
    DRUG METABOLISM REVIEWS, 2003, 35 : 28 - 28
  • [26] Are Circulating Metabolites Important in Drug-Drug Interactions?: Quantitative Analysis of Risk Prediction and Inhibitory Potency
    Yeung, C. K.
    Fujioka, Y.
    Hachad, H.
    Levy, R. H.
    Isoherranen, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (01) : 105 - 113
  • [27] Molecular mechanisms of cytochrome P450 induction: Potential for drug-drug interactions
    Jana, Snehasis
    Paliwal, Jyoti
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2007, 8 (06) : 619 - 628
  • [28] In Silico Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 Isoforms
    Dmitriev, Alexander V.
    Rudik, Anastassia V.
    Karasev, Dmitry A.
    Pogodin, Pavel V.
    Lagunin, Alexey A.
    Filimonov, Dmitry A.
    Poroikov, Vladimir V.
    PHARMACEUTICS, 2021, 13 (04)
  • [29] Quantitative Prediction of Drug-Drug Interactions Involving Inhibitory Metabolites in Drug Development: How Can Physiologically Based Pharmacokinetic Modeling Help?
    Templeton, I. E.
    Chen, Y.
    Mao, J.
    Lin, J.
    Yu, H.
    Peters, S.
    Shebley, M.
    Varma, M. V.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (10): : 505 - 515
  • [30] Drug-Drug Interactions Between Amiodarone and Simvastatin in Human Liver Microsomes
    Wan, Chao
    Zhu, Ning
    CIRCULATION, 2010, 122 (02) : E303 - E304
12345